HVC
FCSC

Healthcare Value Capital’s Fibrocell Science Inc. FCSC Stock Holding History

Healthcare Value Capital’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,000
Closed -$6K – 12
2017
Q4 		$6K Hold
2,000
– – 0.02% 11
2017
Q3 		$31K Hold
2,000
– – 0.06% 13
2017
Q2 		$40K Buy
+2,000
New +$24.7K 0.07% 17

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Healthcare Value Capital's FCSC Position: Q2 2017 in Review

Healthcare Value Capital sold out of Fibrocell Science Inc. (FCSC) in Q2 2017, closing a stake of 3,185 shares — an estimated $39.3K sold.

Healthcare Value Capital first reported a position in FCSC in Q1 2014 and held it in 13 quarters. The position peaked at $831K in Q2 2015. 29 funds tracked by Wall St. Rank hold FCSC as of Q2 2017.

  • Healthcare Value Capital reported no remaining Fibrocell Science Inc. position as of Q2 2017 after selling out during the quarter.
  • Healthcare Value Capital sold 3,185 Fibrocell Science Inc. shares in Q2 2017, an estimated $39.3K.
  • Healthcare Value Capital first reported a position in Fibrocell Science Inc. in Q1 2014 and held it in 13 quarters.
  • Healthcare Value Capital's Fibrocell Science Inc. position peaked at $831K in Q2 2015.
  • 29 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2017.

Based on Healthcare Value Capital's 13F filing for Q2 2017, filed 10 Aug 2017.